Ampio Pharmaceuticals, Inc. (AMPE) Q2 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you and welcome to the Ampio Pharmaceuticals 2021 Second Quarter Earnings Results and Corporate Update Webinar. As a reminder, this call is being recorded and all listeners will be in a listen-only mode. If you would like to ask a question, please dial star 1 on your telephone keypad. If you are accessing this call by webinar, you can submit your question online in the Ask a Question portion of your screen. At this time, I'd like to turn the floor over to Mr. Dan Stokely. Dan, please go ahead. Thank you very much, Catherine. I hope everyone's having a great day. It's our pleasure, me and the rest of the Amphio executive management team, to be present here today. And we'd like to thank each one of you for attending our second quarter 2021 financial results and business update call, either via the phone or webcast. Prior to reading the Safe Harbor forward-looking statement, I'd like to introduce you to the members of the executive management team of Amphio, who will be presenting and or participating on the call today. First, here with us at the company headquarters in Englewood, Colorado, is Mr. Mike Macaluso, the chairman and chief executive officer. We also have present Dr. David Baror, who's director and founder, Holly Cherevka, the company's chief operating officer, and me, Dan Stokely, the chief financial officer. I'd like to start out by first reading our safe harbor statement. These slides and materials, which are not going to be applicable today, but including also any accompanying oral presentation, may contain forward-looking statements about our business. You should not place undue reliance on forward-looking statements, as these statements are based upon our current expectations, forecasts, and assumptions, and are subject to significant risks and un...